Anyanwu Nneoma Confidence JeanStephanie, Oluwatimileyin David Jesutobi, Sunmonu Peace Temitope
Department of Biological Sciences, Faculty of Science and Technology, Bingham University, Karu, Nigeria.
Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria.
Microbiol Insights. 2020 Oct 19;13:1178636120947680. doi: 10.1177/1178636120947680. eCollection 2020.
Malaria and HIV are 2 significant infections of critical public health concern globally. Malaria infection is one of the preceding causes of morbidity and mortality in endemic developing countries, and its co-infections in HIV patients worsen prognosis; with anaemia being the most common haematologic outcome of the infections.
This study was aimed at determining the prevalence of anaemia and malaria co-infection among HIV-infected patients attending selected hospitals in Abuja between February and July 2019.
A cross-sectional study was carried out to detect malaria in 420 HIV-positive patients who were 12 to 67 years old, using enzyme immunoassay and microscopy. A structured questionnaire was used to capture socio-demographic and risk factors ([Frequency of] Use of Malaria preventive Measures, History of anaemia, Blood type, malaria antecedents, and CD4+ Count) while packed cell volume was checked using micro haematocrit reader to determine anaemia status. Data were analysed using IBM SPSS v25.
The mean age of the study participants was 37.5 (±12.48). A total of 142 (33.8%) samples were positive for malaria, and 68 of the HIV-infected patients (16.2%) were anaemic; 4.8% of the 420 patients had malaria co-infection and anaemia simultaneously. More male participants had malaria co-infection (36.0%, = .617) while more female participants had anaemia (22.7%, = .058). Patients aged 61 to 70 years had the highest rates of malaria and those aged 51 to 60 years were most anaemic. Except for patients with normal CD4+ count, those who were more exposed to the evaluated risk factors were more co-infected and anaemic. Malaria co-infection did not significantly affect the onset of anaemia. Test for the validity of Microscopy against Enzyme Immunoassay (EIA) showed 83.1% sensitivity and 98.6% specificity. No association was observed between the variables and the parasitaemia density of the patients.
This study highlighted higher rates of malaria co-infection and anaemia among HIV patients when compared with previous reports in the region although co-infection did not significantly affect anaemia status. Given this trend, strategies must be put in place to checkmate these ailments. Population studies are also advocated.
疟疾和艾滋病毒是全球严重的公共卫生问题中的两种重要感染。疟疾感染是流行的发展中国家发病和死亡的主要原因之一,其在艾滋病毒患者中的合并感染会使预后恶化;贫血是这些感染最常见的血液学后果。
本研究旨在确定2019年2月至7月在阿布贾选定医院就诊的艾滋病毒感染患者中贫血与疟疾合并感染的患病率。
采用横断面研究,使用酶免疫测定法和显微镜检查对420名年龄在12至67岁的艾滋病毒阳性患者进行疟疾检测。使用结构化问卷收集社会人口统计学和风险因素(疟疾预防措施的[使用频率]、贫血病史、血型、疟疾既往史和CD4 +细胞计数),同时使用微量血细胞比容读数器检查血细胞比容以确定贫血状态。数据使用IBM SPSS v25进行分析。
研究参与者的平均年龄为37.5(±12.48)岁。共有142份(33.8%)样本疟疾检测呈阳性,68名艾滋病毒感染患者(16.2%)贫血;420名患者中有4.8%同时患有疟疾合并感染和贫血。男性参与者中疟疾合并感染的比例更高(36.0%,P = 0.617),而女性参与者中贫血的比例更高(22.7%,P = 0.058)。61至70岁的患者疟疾发病率最高,51至60岁的患者贫血最为严重。除CD4 +细胞计数正常的患者外,那些更多暴露于评估风险因素的患者合并感染和贫血的情况更严重。疟疾合并感染对贫血的发生没有显著影响。显微镜检查相对于酶免疫测定法(EIA)的有效性测试显示敏感性为83.1%,特异性为98.6%。未观察到变量与患者寄生虫血症密度之间的关联。
本研究强调,与该地区先前的报告相比,艾滋病毒患者中疟疾合并感染和贫血的发生率更高,尽管合并感染对贫血状态没有显著影响。鉴于这种趋势,必须制定策略来控制这些疾病。还提倡进行人群研究。